Zur Kurzanzeige

dc.contributor.authorNovoa Valentín, Nuria María 
dc.contributor.authorJiménez López, Marcelo Fernando 
dc.contributor.authorAranda Alcaide, José Luis 
dc.contributor.authorRodríguez, María
dc.contributor.authorRamos, Jacinto
dc.contributor.authorGómez Hernández, María Teresa 
dc.contributor.authorVarela, Gonzalo
dc.date.accessioned2025-01-10T12:22:34Z
dc.date.available2025-01-10T12:22:34Z
dc.date.issued2014
dc.identifier.citationNovoa, N., Jimenez, M. F., Aranda, J. L., Rodriguez, M., Ramos, J., Gomez Hernandez, M. T., y Varela, G. (2014). Effect of implementing the European guidelines for functional evaluation before lung resection on cardiorespiratory morbidity and 30-day mortality in lung cancer patients: A case-control study on a matched series of patients. European Journal of Cardio-Thoracic Surgery, 45(4), e89-e93. https://doi.org/10.1093/ejcts/ezt596es_ES
dc.identifier.issn1010-7940
dc.identifier.urihttp://hdl.handle.net/10366/161590
dc.description.abstract[EN] OBJECTIVES: We hypothesized that postoperative cardiorespiratory morbidity and/or 30-day death rates decreased after implementing the new European ERS/ESTS guidelines for functional evaluation before lung resection and tested the hypothesis by means of a case– control study. METHODS: The analysis included a series of 916 consecutive patients who underwent an anatomical pulmonary resection for non-smallcell lung cancer in our centre. Patients were divided into cases (September 2009–August 2012) and controls (December 2002–August 2009). We reviewed the records from a prospective computerized database; the final dataset included no missing data. The primary studied outcomes were the occurrence of cardiorespiratory morbidity or 30-day death after surgery. The patients were 1:1 propensity score matched according to the following variables age, ppoFEV1% and the need of pneumonectomy. RESULTS: After the matching process, 670 cases (335 cases and 335 controls) entered into the study. The rates of pneumonectomy in cases and controls were 5.7 and 13.2%, respectively, (P < 0.0001) in the whole series and 5.7 and 6.9% after matching (P = 0.52). Cardiorespiratory morbidity was 8.1% (27 of 308) in cases and 9.8% (33 of 335) in controls [odds ratio (OR): 0.8; 95% confidence interval (CI): 0.4–1.4]. Thirtyday mortality was 0.90% (3/335) in cases and 1, 2% (4 of 335) in controls (OR: 0.7; 95% CI: 0.1–4.4). CONCLUSIONS: Although we have observed a trend towards lower cardiorespiratory morbidity and 30-day mortality after implementing ERS/ESTS guidelines, the benefit of the guidelines remains unclear. Multicentric analysis including a very large number of cases is needed to demonstrate statistically the effectiveness of the guidelines to reduce operative mortality and cardiorespiratory morbidity. Maybe the effect could be easier demonstrated in series with higher operative mortality or morbidityes_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectClinical guidelinees_ES
dc.subjectSurgical risk evaluationes_ES
dc.subjectPostoperative mortalityes_ES
dc.subjectPostoperative cardiorespiratory morbidityes_ES
dc.subject.meshLung *
dc.subject.meshPostoperative Period *
dc.titleEffect of implementing the European guidelines for functional evaluation before lung resection on cardiorespiratory morbidity and 30-day mortality in lung cancer patients: a case-control study on a matched series of patientses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://academic.oup.com/ejcts/article/45/4/e89/361628es_ES
dc.subject.unesco3213 Cirugíaes_ES
dc.subject.unesco3201.01 Oncologíaes_ES
dc.identifier.doi10.1093/ejcts/ezt596
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1873-734X
dc.journal.titleEuropean Journal of Cardio-Thoracic Surgeryes_ES
dc.volume.number45es_ES
dc.issue.number4es_ES
dc.page.initiale89es_ES
dc.page.finale93es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decspulmón *
dc.subject.decsperíodo postoperatorio *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional